Corbus Pharma (CRBP) Reports Q2 Loss of $0.11/Share
Tweet
Share
E-mailGet Alerts CRBP Hot Sheet
Join SI Premium – FREE
Corbus Pharma (NASDAQ: CRBP) reported Q2 EPS of ($0.11), versus ($0.10) reported last year.
For earnings history and earnings-related data on Corbus Pharma (CRBP) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Klarna shares tumble on weak full-year revenue guidance
- Prenetics Global (PRE) Tops Q2 EPS by 18c
- Cummins wins battery storage contract for U.S. data center project
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
